Anti-CD25 monoclonal antibody enhances the protective efficacy of Schistosoma japonicum GST vaccine via inhibition of CD4+CD25+Foxp3+ regulatory T cells

Chun‐lian Tang(Wuchang University of Technology), Zhiming Liu(Xiamen University), Liang-yu Cheng(Wuchang University of Technology), Lan-fang Cheng(Wuchang University of Technology), Jin Yang(First Affiliated Hospital of Xi'an Jiaotong University)
Parasitology Research
August 21, 2017
10.1007/s00436-017-5581-0
Cited by 26

Related Papers

Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial
|BMJ|2023|82
Effect of CD4+CD25+ regulatory T cells on the immune evasion of Schistosoma japonicum
|Parasitology Research|2010|45
Nicking enzyme-assisted signal-amplifiable Hg2+ detection using upconversion nanoparticles
|Analytica Chimica Acta|2019|39
Helminths protect against type 1 diabetes: effects and mechanisms
|Parasitology Research|2019|30
Cloning and characterization of a bone morphogenetic protein homologue of Schistosoma japonicum
|Experimental Parasitology|2013|29